Quest Diagnostics IncNYSE:DGX
- LAST PRICE162.0000
- TODAY'S CHANGE (%)1.5600 (0.9723%)
- Bid / Lots161.9700/ 4
- Ask / Lots162.0700/ 3
- Open / Previous Close160.8800 / 160.4400
- Day Range
- 52 Week Range
- Volume277,325
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DGX |
|---|---|---|
| 09:32 ET | 9524 | 160.88 |
| 09:33 ET | 700 | 160.76 |
| 09:35 ET | 850 | 161.27 |
| 09:42 ET | 500 | 161.175 |
| 09:44 ET | 3822 | 162.155 |
| 09:46 ET | 948 | 162.065 |
| 09:48 ET | 800 | 162.03 |
| 09:50 ET | 3197 | 161.485 |
| 09:51 ET | 3222 | 161.625 |
| 09:57 ET | 200 | 161.925 |
| 10:00 ET | 1345 | 162.075 |
| 10:02 ET | 2157 | 162.3 |
| 10:04 ET | 3343 | 162.295 |
| 10:06 ET | 991 | 162.36 |
| 10:08 ET | 272 | 162.51 |
| 10:09 ET | 2792 | 162.53 |
| 10:11 ET | 100 | 162.515 |
| 10:13 ET | 2040 | 162.515 |
| 10:15 ET | 378 | 162.58 |
| 10:18 ET | 200 | 162.61 |
| 10:20 ET | 515 | 162.56 |
| 10:22 ET | 598 | 162.61 |
| 10:24 ET | 600 | 162.66 |
| 10:26 ET | 2415 | 162.575 |
| 10:27 ET | 1574 | 162.555 |
| 10:29 ET | 3345 | 162.22 |
| 10:31 ET | 100 | 162.24 |
| 10:33 ET | 629 | 162.365 |
| 10:36 ET | 921 | 162.32 |
| 10:40 ET | 1103 | 162.15 |
| 10:42 ET | 2734 | 162.135 |
| 10:44 ET | 800 | 162.07 |
| 10:45 ET | 6965 | 162.32 |
| 10:47 ET | 1423 | 162.26 |
| 10:49 ET | 500 | 162.485 |
| 10:51 ET | 4649 | 162.36 |
| 10:54 ET | 1246 | 162.13 |
| 10:56 ET | 212 | 162.03 |
| 10:58 ET | 200 | 161.905 |
| 11:00 ET | 1100 | 161.92 |
| 11:02 ET | 100 | 161.92 |
| 11:03 ET | 901 | 162.01 |
| 11:05 ET | 1200 | 162.045 |
| 11:07 ET | 400 | 162.16 |
| 11:09 ET | 1823 | 161.98 |
| 11:12 ET | 500 | 161.985 |
| 11:14 ET | 500 | 161.96 |
| 11:16 ET | 600 | 161.8604 |
| 11:18 ET | 200 | 161.96 |
| 11:20 ET | 200 | 161.905 |
| 11:21 ET | 675 | 161.96 |
| 11:23 ET | 1004 | 162.07 |
| 11:25 ET | 200 | 162.12 |
| 11:27 ET | 1566 | 162.13 |
| 11:30 ET | 1800 | 162.07 |
| 11:32 ET | 1608 | 162.12 |
| 11:34 ET | 1118 | 162.27 |
| 11:36 ET | 300 | 162.28 |
| 11:38 ET | 600 | 162.25 |
| 11:39 ET | 1900 | 162.17 |
| 11:41 ET | 1097 | 162.215 |
| 11:43 ET | 700 | 162.235 |
| 11:45 ET | 700 | 162.22 |
| 11:48 ET | 500 | 162.23 |
| 11:50 ET | 1204 | 162.25 |
| 11:52 ET | 702 | 162.22 |
| 11:54 ET | 4042 | 162.265 |
| 11:56 ET | 2170 | 162.276 |
| 11:57 ET | 703 | 162.21 |
| 11:59 ET | 611 | 162.2525 |
| 12:01 ET | 1842 | 162.24 |
| 12:03 ET | 402 | 162.23 |
| 12:06 ET | 4773 | 162.14 |
| 12:08 ET | 819 | 162.105 |
| 12:10 ET | 250 | 162.105 |
| 12:12 ET | 6338 | 162.15 |
| 12:14 ET | 5492 | 162.18 |
| 12:15 ET | 700 | 162.15 |
| 12:17 ET | 300 | 162.145 |
| 12:19 ET | 592 | 162.165 |
| 12:21 ET | 1043 | 162.245 |
| 12:24 ET | 3109 | 162.405 |
| 12:26 ET | 100 | 162.43 |
| 12:28 ET | 2184 | 162.46 |
| 12:30 ET | 1012 | 162.52 |
| 12:32 ET | 821 | 162.5 |
| 12:33 ET | 300 | 162.5 |
| 12:35 ET | 200 | 162.485 |
| 12:37 ET | 607 | 162.59 |
| 12:39 ET | 200 | 162.64 |
| 12:42 ET | 600 | 162.585 |
| 12:44 ET | 200 | 162.62 |
| 12:46 ET | 2026 | 162.495 |
| 12:48 ET | 200 | 162.415 |
| 12:50 ET | 1200 | 162.46 |
| 12:53 ET | 700 | 162.44 |
| 12:55 ET | 1202 | 162.25 |
| 12:57 ET | 100 | 162.25 |
| 01:00 ET | 500 | 162.27 |
| 01:02 ET | 100 | 162.24 |
| 01:04 ET | 1730 | 162 |
| 01:06 ET | 100 | 161.99 |
| 01:09 ET | 553 | 162.06 |
| 01:13 ET | 300 | 161.98 |
| 01:15 ET | 3101 | 161.82 |
| 01:18 ET | 674 | 161.86 |
| 01:20 ET | 300 | 161.8233 |
| 01:22 ET | 100 | 161.815 |
| 01:24 ET | 200 | 161.82 |
| 01:26 ET | 842 | 161.855 |
| 01:27 ET | 559 | 161.845 |
| 01:29 ET | 934 | 161.84 |
| 01:31 ET | 100 | 161.82 |
| 01:33 ET | 100 | 161.86 |
| 01:36 ET | 358 | 161.855 |
| 01:38 ET | 400 | 161.88 |
| 01:40 ET | 200 | 161.91 |
| 01:42 ET | 134 | 161.865 |
| 01:44 ET | 900 | 161.83 |
| 01:45 ET | 3103 | 162.02 |
| 01:47 ET | 1406 | 161.995 |
| 01:49 ET | 100 | 162 |
Nov 12, 2024
Press Release: Quest Diagnostics Declares Quarterly Cash Dividend, from 5:57PM ET on Tuesday Nov 12, 2024 by Dow Jones
5:57PM ET on Tuesday Nov 12, 2024 by Dow JonesQuest Diagnostics Declares Quarterly Cash Dividend, from 5:57PM ET on Tuesday Nov 12, 2024 by Dow Jones
5:57PM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 7, 2024
My Quest Story - Malissa Mueller, from 1:31PM ET on Thursday Nov 07, 2024 by Dow Jones
1:31PM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 5, 2024
Nonprofit Partners With Newark Black Churches To Bridge Health Disparities, from 4:46PM ET on Tuesday Nov 05, 2024 by Dow Jones
4:46PM ET on Tuesday Nov 05, 2024 by Dow Jones
Oct 29, 2024
Career Progression - Jessie Hutchens Maxwell, from 11:36AM ET on Tuesday Oct 29, 2024 by Dow Jones
11:36AM ET on Tuesday Oct 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Quest Diagnostics Inc | 17.9B | 21.7x | +7.78% |
Labcorp Holdings Inc | 19.7B | 46.4x | -13.71% |
Natera Inc | 18.1B | -84.3x | --- |
DaVita Inc | 13.1B | 17.0x | +15.72% |
Healthpeak Properties Inc | 14.6B | 44.3x | -20.31% |
Universal Health Services Inc | 13.3B | 13.2x | +4.42% |
Company Information
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. The Company also focuses on artificial intelligence (AI) and digital pathology solutions for biopharmaceutical companies and pathology laboratories. It has implemented AI, digital and automation technologies across several laboratory and business functions.
Contact Information
- Headquarters
- 500 Plaza DriveSECAUCUS, NJ, United States 07094
- Phone
- 973-520-2700
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board, President, Chief Executive Officer
- James Davis
- Chief Financial Officer, Executive Vice President
- Sam Samad
- Senior Vice President, Chief Information and Digital Officer
- Murali Balakumar
- Senior Vice President, General Counsel
- Michael Prevoznik
- Senior Vice President, Chief Commercial Officer
- Mark Delaney
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $17.9B |
|---|---|
Revenue (TTM) | $9.5B |
Shares Outstanding | 111.6M |
Dividend Yield | 1.85% |
Annual Dividend Rate | 3.0000 USD |
Ex-Dividend Date | 01-14-25 |
Pay Date | 01-29-25 |
Beta | 0.89 |
EPS | $7.45 |
Book Value | $56.82 |
P/E Ratio | 21.7x |
Price/Sales (TTM) | 1.9 |
Price/Cash Flow (TTM) | 13.4x |
Operating Margin | 13.13% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
